Пређи на садржај

Онкологија (педијатрија)

Клинички резултати

Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children's Oncology Group trial AAML0531. (отвара нови прозор)

Gamis AS, Alonzo TA, Meshinchi S, Sung L, Gerbing RB, Raimondi SC, Hirsch BA, Kahwash SB, Heerema-McKenney A, Winter L, Glick K, Davies SM, Byron P, Smith FO, Aplenc R

Извор‎: J Clin Oncol 2014;32(27):3021-32.

Индекс‎: PubMed 25092781

DOI‎: 10.1200/JCO.2014.55.3628

https://www.ncbi.nlm.nih.gov/pubmed/25092781 (отвара нови прозор)

Red blood cell transfusion and outcome in cancer. (отвара нови прозор)

Iqbal N, Haider K, Sundaram V, Radosevic J, Burnouf T, Seghatchian J, Goubran H

Извор‎: Transfus Apher Sci 2017;56(3):287-90.

Индекс‎: PubMed 28602484

DOI‎: 10.1016/j.transci.2017.05.014

https://www.ncbi.nlm.nih.gov/pubmed/28602484 (отвара нови прозор)

Bloodless cancer treatment results of patients who do not want blood transfusion: single center experience of 77 cases. (отвара нови прозор)

Oh SY, Kim SH, Kwon HC, Lee S, Kim KH, Kwon KA, Lee JH, Lee KY, Kim HJ

Извор‎: Support Care Cancer 2010;18(10):1341-6.

Индекс‎: PubMed 19841950

DOI‎: 10.1007/s00520-009-0759-3

https://www.ncbi.nlm.nih.gov/pubmed/19841950 (отвара нови прозор)